Predictive modeling of schizophrenia from genomic data: Comparison of polygenic risk score with kernel support vector machines approach.


Journal

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
ISSN: 1552-485X
Titre abrégé: Am J Med Genet B Neuropsychiatr Genet
Pays: United States
ID NLM: 101235742

Informations de publication

Date de publication:
01 2019
Historique:
received: 20 07 2018
revised: 03 09 2018
accepted: 09 11 2018
pubmed: 6 12 2018
medline: 10 3 2020
entrez: 6 12 2018
Statut: ppublish

Résumé

A major controversy in psychiatric genetics is whether nonadditive genetic interaction effects contribute to the risk of highly polygenic disorders. We applied a support vector machines (SVMs) approach, which is capable of building linear and nonlinear models using kernel methods, to classify cases from controls in a large schizophrenia case-control sample of 11,853 subjects (5,554 cases and 6,299 controls) and compared its prediction accuracy with the polygenic risk score (PRS) approach. We also investigated whether SVMs are a suitable approach to detecting nonlinear genetic effects, that is, interactions. We found that PRS provided more accurate case/control classification than either linear or nonlinear SVMs, and give a tentative explanation why PRS outperforms both multivariate regression and linear kernel SVMs. In addition, we observe that nonlinear kernel SVMs showed higher classification accuracy than linear SVMs when a large number of SNPs are entered into the model. We conclude that SVMs are a potential tool for assessing the presence of interactions, prior to searching for them explicitly.

Identifiants

pubmed: 30516002
doi: 10.1002/ajmg.b.32705
pmc: PMC6492016
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-85

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0800509
Pays : United Kingdom

Informations de copyright

© 2018 The Authors. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics published by Wiley Periodicals, Inc.

Références

Bioinformatics. 2011 Jun 1;27(11):1462-5
pubmed: 21471009
BMC Bioinformatics. 2004 Sep 01;5:120
pubmed: 15339344
Nat Rev Genet. 2009 Jun;10(6):392-404
pubmed: 19434077
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Genet Epidemiol. 2012 Feb;36(2):88-98
pubmed: 22851472
Trends Genet. 2018 Apr;34(4):301-312
pubmed: 29331490
Genet Epidemiol. 2018 Jun;42(4):366-377
pubmed: 29532500
Eur J Hum Genet. 2008 Feb;16(2):229-35
pubmed: 17971837
PLoS One. 2011 May 12;6(5):e14802
pubmed: 21589856
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Brain. 2015 Dec;138(Pt 12):3673-84
pubmed: 26490334
Am J Med Genet B Neuropsychiatr Genet. 2019 Jan;180(1):80-85
pubmed: 30516002
Mol Psychiatry. 2013 Jun;18(6):708-12
pubmed: 22614287
BMC Bioinformatics. 2009 Jan 30;10 Suppl 1:S65
pubmed: 19208169
BMC Bioinformatics. 2010 Feb 27;11:110
pubmed: 20187966
Semin Nucl Med. 1978 Oct;8(4):283-98
pubmed: 112681
BMC Genet. 2004 Dec 10;5:32
pubmed: 15588316
Nat Rev Genet. 2012 Jul 10;13(8):537-51
pubmed: 22777127
Nat Genet. 2012 Mar 18;44(4):369-75, S1-3
pubmed: 22426310
Nat Genet. 2015 Jul;47(7):702-9
pubmed: 25985137
Nature. 2014 Apr 10;508(7495):249-53
pubmed: 24572353
Nat Biotechnol. 2006 Dec;24(12):1565-7
pubmed: 17160063
J Clin Epidemiol. 2015 Jun;68(6):627-36
pubmed: 25704724
Biomed Res Int. 2013;2013:432375
pubmed: 24228248
Nat Genet. 2012 Feb 19;44(3):247-50
pubmed: 22344220
Genet Epidemiol. 2008 Feb;32(2):152-67
pubmed: 17968988
BMC Genet. 2010 Apr 23;11:26
pubmed: 20416077
Ann Neurol. 2015 Apr;77(4):582-91
pubmed: 25773351

Auteurs

Timothy Vivian-Griffiths (T)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Emily Baker (E)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Karl M Schmidt (KM)

School of Mathematics, Cardiff University, Cardiff, United Kingdom.

Matthew Bracher-Smith (M)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

James Walters (J)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Andreas Artemiou (A)

School of Mathematics, Cardiff University, Cardiff, United Kingdom.

Peter Holmans (P)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Michael C O'Donovan (MC)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Michael J Owen (MJ)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Andrew Pocklington (A)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Valentina Escott-Price (V)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH